Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.95
Bid: 2.90
Ask: 3.00
Change: 0.00 (0.00%)
Spread: 0.10 (3.448%)
Open: 2.95
High: 2.95
Low: 2.95
Prev. Close: 2.95
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Harvest Minerals CFO Leaves To Save Cost

Tue, 14th Apr 2020 14:51

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Harvest Minerals Ltd - David Edghill departs as chief financial officer as part of company cost savings. Executive Chair Brian McMaster will oversee finance function. "The company remains registered in Australia with operations in Brazil and, as such, it has become clear that there are no efficiency gains in having a finance function in the UK," McMaster explained. Additionally, Frank Moxon steps down as non-executive director from June 30 "to pursue other interests".

----------

Dart Group PLC - Appoints Robin Terrell as independent non-executive director, starting immediately. Terrell was chief customer officer for Tesco PLC, having previously served as UK managing director for Amazon.com Inc and also MD of John Lewis Direct.

----------

SVM UK Emerging Fund PLC - Ian Gray hired as a non-executive director, as Tony Puckridge retires, both effective from March 6. Gray is an accountant who also is a non-executive director of DX Group PLC.

----------

Baronsmead Second Venture Trust PLC - Ian Orrock to retire from board on May 1, replaced as senior independent director by Malcolm Groat.

----------

Monks Investment Trust PLC - Hires Claire Boyle as non-executive director from May 1. Worked in equity investment for Robert Fleming Investment Management, American Express Asset Management, and Oxburgh Partners LLP.

----------

ValiRx PLC - George Morris resigns as director immediately.

----------

Idox PLC - Oliver Scott steps down as non-executive director, replaced by Alice Cummings, both immediately. Cummings was chief financial officer of InHealth Group, a healthcare services firm.

----------

Orient Telecoms PLC - Hires Wong Chee Keong as new non-executive chair. Wong has 40 years of experience in the telecommunications industry in Malaysia, Orient noted.

----------

Star Phoenix Group Ltd - Meng YuFeng joins board as nominee of Beijing Sibo Investment Management LP, a large shareholder. Meng has worked in the US, Australia and China in a 30-year career in management and consulting.

----------

Ocean Wilsons Holdings Ltd - Fiona Beck hired as non-executive director from Monday. She was chief executive officer of Southern Cross Cable Network, a submarine fibreoptic cable company connecting New Zealand and Australia to the US.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2016 08:50

ValiRx Receives Approval To Submit Application For Cancer Drug Trial

Read more
7 Jul 2016 07:50

ValiRx Sells TRAC Technology To Germany's Sovicell For EUR800,000

Read more
13 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jun 2016 09:19

ValiRx Highlights Progress With VAL201 Lead Compound, VAL401 Venture

Read more
19 May 2016 15:44

ValiRx updates market on 'significant' 2015

(ShareCast News) - Lifesciences company ValiRx reported on a "significant year" on Thursday, talking up its capital restructure and technical advancements in the 2015 calendar year. The AIM-traded firm, which focuses on cancer therapeutics and diagnostics for personalised medicine, said its Phase I/

Read more
19 May 2016 10:29

ValiRx Loss Narrows As Progress Is Made On Cancer Compounds

Read more
19 May 2016 09:23

ValiRx Says ValiSeek Begins Manufacturing VAL401 For Clinical Trial

Read more
29 Apr 2016 07:50

ValiRx Says ValiSeek Gets US Patent For VAL401 In Adenocarcinoma

Read more
19 Apr 2016 14:45

ValiRx Shares Fall After Bracknor Converts GBP200,000 Of Loan Notes (ALLISS)

Read more
1 Apr 2016 14:28

ValiRx Receives Conversion Notice For GBP90,000 From Bracknor (ALLISS)

Read more
21 Mar 2016 08:29

ValiRx Strikes GBP4 Million Convertible Funding Deal With Bracknor (ALLISS)

Read more
17 Mar 2016 09:07

ValiRx Hires Consultancy Firm Burns McClellan To Boost US Profile

Read more
17 Feb 2016 13:04

ValiRx Raises Funds To Back Ongoing Drug Trials (ALLISS)

Read more
16 Feb 2016 13:17

ValiRx achieves success in latest VAL201 trial

(ShareCast News) - ValiRx was pressing ahead with the trial process for its VAL201 trial treatment on Tuesday, following positive results from the most recent tranche of test patients. The AIM-traded life science company, with a focus on cancer diagnostics and therapeutics for personalised medicine,

Read more
16 Feb 2016 09:16

ValiRx Says Final Dose Escalation For VAL201 Trials Approved

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.